[Ip-health] Trump and Prescription Drug Prices
james.love at keionline.org
Wed Nov 16 23:41:19 PST 2016
Relevant is this from his campaign:
on, N.H., that Medicare, a huge buyer of prescription drugs, could "save
$300 billion" a year if it negotiated discounts.
"We don't do it," he said. "Why? Because of the drug companies."
On Wed, Nov 16, 2016 at 10:40 PM, Matthew Flynn <matthewflynn2 at gmail.com>
> "Donald Trump and his congressional allies are making big plans to repeal
> the Affordable Care Act and overhaul other government health programs.
> But the president-elect appears to have downgraded plans to act
> aggressively to control rising drug prices, handing the pharmaceutical
> industry an early victory and providing another illustration of the
> influence of lobbyists on the new Trump administration, despite Trump’s
> promise to “drain the swamp” of special interests in Washington."
> Ip-health mailing list
> Ip-health at lists.keionline.org
James Love. Knowledge Ecology International
KEI DC tel: +1.202.332.2670, US Mobile: +1.202.361.3040, Geneva Mobile:
More information about the Ip-health